WELCOME TO PAA’s CLINICAL RESEARCH CENTER
PAA’s Clinical Research Center is primarily focused on conducting FDA approved Phase I-IV trials of new pharmaceutical treatments. Over the past several years, we have participated in over 150 clinical trials for asthma, allergy, COPD, as well as many other pulmonary disorders. Our highly experienced staff includes three clinical research coordinators certified in pulmonary and laboratory procedures. Additionally, PAA’s physicians have extensive experience in clinical research and are available for consultation on the design and implementation of clinical studies. Participation in clinical trials offers the physicians at PAA an opportunity to keep on the forefront of new developments in the treatment of respiratory diseases. Furthermore, it offers you an opportunity to experience new medications and devices before they are available to the public.
FOR MORE INFORMATION YOU MAY REACH US AT 908-934-0440
REMEMBER - TODAY’S CLINICAL TRIALS ARE TOMORROW’S MEDICAL BREAKTHROUGH
Medical care and testing related to the trials is often free and patients may also be compensated for time and travel. We invite you to call and tour our facility, meet our research staff and discuss current clinical trials and upcoming opportunities.
Your rights and safety are important to us. A patient’s rights and safety are protected in two important ways:
Any doctor conducting a clinical trial by a pharmaceutical company or NIH must obtain approval from and Institutional Review Board. The review board, composed of doctors and lay people, examines the study’s protocol to ensure the patient’s rights are protected, and that the study does not present an undue or unnecessary risk to the patient.
Anyone participating in a clinical trial in the United States must sign an “informed consent.” This consent details the nature of the study, risks involved, and outline of study visits. The informed consent tells patients that they have a right to leave the study at any time.
- COPD (emphysema/chronic bronchitis)
- Interstitial Pulmonary Fibrosis
- Pediatric/adult depression study
Patients should talk with their doctors and any family member when considering participation.
We want you to feel comfortable about your decision and feel free to ask any questions. In
addition to our medication trials, our facility also conducts cutting edge device trials, validation
of questionnaire studies as well as simple “one-time-only” blood studies.
- Dr. John Oppenheimer, Co-Director
- Dr. Robert Sussman, Co-Director
- Virginia Hala, RN, CCRC,
Manager of Clinical Research (ext. 1900) firstname.lastname@example.org
- Marissa Rienton-Lim, CCRC,
Senior Clinical Research Coordinator (ext. 1902) email@example.com
- Kathleen Izzo, RRT,
Clinical Research Coordinator (ext. 1903) firstname.lastname@example.org
- Hazel Scherb,
Regulatory Specialist (ext. 1904) email@example.com